Epizootic hemorrhagic disease virus (EHDV) is a Culicoides transmitted orbivirus that causes haemorrhagic disease in wild and domestic ruminants. A collection of 44 EHDV isolated from 2008 to 2012 was fully sequenced and analysed phylogenetically. Serotype 2 viruses were the dominant serotype all years except 2012 when serotype 6 viruses represented 63 % of the isolates. High genetic similarity (.94 % identity) between serotype 1 and 2 virus VP1, VP3, VP4, VP6, NS1, NS2 and NS3 segments prevented identification of reassortment events for these segments. Additionally, there was little genetic diversity (.96 % identity) within serotypes for VP2, VP5 and VP7. Preferential reassortment within the homologous serotype was observed for VP2, VP5 and VP7 segments for type 1 and type 2 viruses. In contrast, type 6 viruses were all reassortants containing VP2 and VP5 derived from an exotic type 6 with the remaining segments most similar to type 2 viruses. These results suggest that reassortment between type 1 and type 2 viruses requires conservation of the VP2, VP5 and VP7 segment constellation while type 6 viruses only require VP2 and VP5 and are restricted to type 2-lineage VP7. As type 6 VP2 and VP5 segments were exclusively identified in viruses with type 2-derived VP7, these results suggest functional complementation between type 2 and type 6 VP7 proteins.
INTRODUCTION
Epizootic haemorrhagic disease is an infectious disease caused by viruses belonging to the species Epizootic hemorrhagic disease virus (EHDV) within the genus Orbivirus and family Reoviridae (Savini et al., 2011) . The virus is transmitted by insects of the genus Culicoides (Savini et al., 2011) . EHDV periodically causes disease in white-tailed deer, pronghorn antelope and desert bighorn sheep (Couvillion et al., 1980; Jessup, 1985; Savini et al., 2011; Stallknecht et al., 1995) . EHDV is primarily subacute in cattle with occasional outbreaks of clinical disease (Stallknecht et al., 1995) . EHDV is a significant problem for the livestock industries in the Mediterranean Basin, especially Israel, Morocco, Algeria, Tunisia, Jordan and Turkey (Savini et al., 2011; Yadin et al., 2008) .
EHDV is both genetically and morphologically similar to Bluetongue virus (BTV), the type species of the genus that causes disease in ovine, bovine and other species (Jessup, 1985; Savini et al., 2011; Stallknecht et al., 1995; Yadin et al., 2008) . Both EHDV and BTV contain a ten-segmented double-stranded RNA genome (Savini et al., 2011) . Each segment encodes a single protein, with a total of seven structural proteins (VP1 to VP7) and four non-structural proteins (NS1, NS2, NS3 and NS3a) (Anthony et al., 2009a, b; Mecham & Dean, 1988; Savini et al., 2011) . The virion outer layer is composed of VP2 and VP5 trimers that are involved in viral attachment and penetration of the host cell (Anthony et al., 2009c; Mecham & Dean, 1988; Savini et al., 2011) . VP2 and VP5 are the most variable viral proteins and specificity of their interactions with neutralizing antibodies (especially VP2) determines the virus serotype (Anthony et al., 2009c; Mecham & Dean, 1988; Savini et al., 2011) . VP7 forms the outer core layer and provides a surface for VP2 and VP5 attachment (Anthony et al., 2009a; Mecham & Dean, 1988; Savini et al., 2011) . VP3 forms the inner subcore layer and surrounds VP1, VP4 and VP6 as well as the ten linear dsRNA segments (Anthony et al., 2009a; Mecham & Dean, 1988; Savini et al., 2011) . VP3 is an RNA-binding protein which interacts with both the viral RNA genome and the minor proteins VP1, VP4 and VP6 (Anthony et al., 2009a; Mecham & Dean, 1988; Savini et al., 2011) . Self-assembly of VP3 controls the size and organization of the capsid structure (Anthony et al., 2009a) . VP1, a highly conserved protein, functions as a viral RNA-dependent RNA polymerase (RdRP) (Anthony et al., 2009a; Mecham & Dean, 1988; Savini et al., 2011) .
VP4 is the capping enzyme, and VP6 is believed to be the viral helicase (Anthony et al., 2009a; Mecham & Dean, 1988; Savini et al., 2011) .
Based on the antigenic and genetic analyses of the two outer capsid proteins (VP2 and VP5), eight serotypes of EHDV are proposed (Campbell & St George, 1986) . EHDV serotypes 3 and 4 are reported in Africa (Allison et al., 2010; Lee et al., 1974; Moore, 1974; Moore & Kemp, 1974) . EHDV serotypes 5, 6, 7 and 8 are reported in Australia (Allison et al., 2010; St George et al., 1983) . EHDV-6 has been identified in Bahrain, the Sultanate of Oman, Sudan, Morocco and Algeria (Mohammed et al., 1996) . Historically, in the USA only two serotypes, EHDV-1 (New Jersey strain) and EHDV-2 (Alberta strain), were identified (Allison et al., 2010) . However, in 2006, a novel reassortant serotype 6 EHDV containing two variable surface antigens (VP2 and VP5) from an exotic EHDV-6 with the remaining segments derived from endemic EHDV-2 was isolated from moribund and dead white-tailed deer in Indiana and Illinois (Allison et al., 2010) . Subsequently, reassortant type 6 EHDV was identified in several other states demonstrating that the virus is geographically widespread (Allison et al., 2010) . This strain is currently endemic in the USA (Allison et al., 2010) . Reassortment between native and exotic EHDV illustrates the plasticity of EHDV and their ability to become established in new environmental niches (Allison et al., 2010) .
EHDV infection can be very debilitating and is often fatal in wild ungulates, including white-tailed deer, mule deer and antelope (Savini et al., 2011) . However, EHDV infection is generally not apparent or very mild in livestock (Savini et al., 2011) . Despite this, numerous EHDV outbreaks and its introduction to new areas suggest EHDV is clinically and economically important (Savini et al., 2011) . Consequently, surveillance is warranted in livestock and wild deer populations.
Whole genome sequencing of the EHDV isolated from clinical submissions to the Newport Laboratories over a 4 year period was performed to assess EHDV genetic diversity and population dynamics.
RESULTS AND DISCUSSION
Whole genome sequencing and phylogenetic analysis
Tissue and blood samples were collected from white-tailed deer exhibiting clinical signs of EHDV infection and submitted to Newport Laboratories from 2008 to 2012 (Table 1) . EHDV positive samples were identified using real-time quantitative reverse transcription PCR and cultured on baby hamster kidney (BHK) cells (Clavijo et al., 2010) . Forty-four viruses were isolated over this time period and subjected to genome sequencing. Predicted serotypes were determined by homology of VP2 and VP5 genes to reference strains. Type 2 viruses were the most prevalent serotype over this time period, accounting for 57 % of the isolates (Table 2) . Type 6 viruses represented 32 % of our samples; however, 63 % of EHDV were isolated in 2012. Type 1 was least prevalent, at 11 %, and was not identified in 2012. The results suggest that type 1 was not widespread in the sample set used for the studies. Although type 2 was prevalent, type 6 viruses became dominant in 2012 in the sampling area. Type 2 viruses were identified in all regions sampled and type 6 viruses were also widespread, with isolates from Texas and the Midwest. Type 1 viruses were only identified in Texas and Oklahoma. Co-circulation of type 1, 2 and 6 viruses was seen in Texas in 2010 and 2011, the state most heavily represented in our sample set.
Phylogenetic analysis (VP2, VP5 and VP7)
Phylogenetic comparisons were constructed in MEGA version 5.05 using the maximum-likelihood algorithm and bootstrapped using 1000 replicates. Phylogenetic trees of all ten segments of EHDV isolates are shown in Figs 1, S1, S2 and S3 (available in JGV Online). Comparison of the VP2 sequences to reference viruses identified 97.3-98.4 % nucleotide identity between type 2 viruses, 96.6298.7 % identity between type 1 viruses and 97.4-97.7 % identity between type 6 viruses (Table S1 ). Although we observed greater than 96 % identity between VP2 gene sequences within each serotype, there was only 47-53 % identity between type 1, 2 and 6 viruses.
Similarly, comparisons of complete VP5 sequences to the published reference viruses identified 96.0-97.5 % nucleotide identity between type 2 viruses, 97.7-98.3 % identity between type 6 viruses and 96.4-96.9 % identity between type 1 viruses (Table S1 ). Inter-subtype sequence identity was only 64-69 %.
Likewise, comparisons of complete VP7 sequences to the published reference viruses identified 97.8-98.6 % nucleotide identity between type 2 isolates, 97 % identity between type 1 isolates and only 78-80 % identity between type 1 and type 2 viruses (Table S1 ). Moreover, all type 1 and type 2 viruses demonstrates preferential reassortment for VP2, VP5 and VP7 within the homologous serotype (Fig. 2) . In the virion, VP2 and VP5 are arranged on the outer core layer formed by VP7. Preferential reassortment observed for type 1 and type 2 viruses suggests incompatibility between the surface proteins VP2 and VP5 and the outer core protein VP7 from the heterologous serotype. Similar to previous studies, the results also demonstrate that VP2 and VP5 from type 6 are compatible with VP7 from serotype 2. In contrast, reassortment by another orbivirus, BTV, was shown to freely occur for all segments (Shaw et al., 2013) . Alternate explanations for the observed preferential reassortment could be the limited size of our sample set prohibiting us from identifying all genotypes as well as lack of co-infection with multiple types preventing reassortment in vivo. Co-circulation of type 1, 2 and 6 viruses in Texas in 2010 and 2011 demonstrates that all three types were present in the same state at the same time,
Whole genome analysis of EHDV theoretically allowing for reassortment. For EHDV, reverse genetics is needed to conclusively demonstrate preferential reassortment.
High genetic identity (.94 %) was observed between type 1 and type 2 reference viruses for segments encoding VP1, VP3, VP4, VP6, NS1, NS2 and NS3, preventing conclusive identification of reassortment events between these segments for type 1 and type 2 viruses (Table S1 ). Although the phylogenetic analysis showed subclades which are supported by strong bootstrap values, the branch lengths among isolates are very short, indicating a very low level of genetic variation among the segments (Figs S1, S2 and S3). Overall the results indicate that within type 1 and type 2 viruses, unlike VP2, VP5 and VP7 there are no serotypespecific genetic traits common to segments encoding VP1, VP3, VP4, VP6, NS1, NS2 and NS3 suggesting that genes (Murphy et al., 2005) . These results were somewhat surprising as EHDV, an RNA virus, has a viral RNA polymerase that lacks a proof-reading mechanism (Holland et al., 1982) . Additionally, the segmented genome facilitates reassortment within the species. However, our finding supports a growing body of evidence that EHDV, similar to many orbiviruses, is genetically stable (Murphy et al., 2005) .
In the mosquito-borne Yellow fever virus, a single-stranded RNA virus, there was only a 6.8 % variation among isolates collected over 45 years from a region where transmission is seasonal, multiple species are involved and regular epidemics of diseases in humans occur (Mutebi et al., 2001) . Similar observations were also made for another single-stranded RNA virus, vesicular stomatitis virus, which exists in an enzootic cycle, suggesting that there is genetic stability in this virus (Stallknecht et al., 1985) . Furthermore, Jenkins et al. (2002) analysed nucleotide substitution rates among 50 RNA viruses and postulated that selection pressure in multiple hosts contributes to slightly lower rates of evolution among vector-borne viruses when compared to non-vector-borne viruses. Such selection pressure might be responsible for less genetic diversity where mutations can disrupt the balance between efficient virus replication and maximal transmission. Moreover, the double-stranded RNA genome of BTV and EHDV likely plays a role in viral genetic stability. Since EHDV is a vector-borne virus, the high level of genetic identity between the isolates suggests a stable host-virus relationship.
Serum neutralization assay
A subset of EHDV isolates from each serotype was randomly selected and assayed by serum neutralization with reference antiserum ( Virus growth. Virus was isolated either from tissue or blood samples.
Filtrates from the blood samples (either whole blood or plasma) were used to inoculate BHK cells. Tissue samples were mechanically homogenized in 1 ml Dulbecco's Modified Eagle's Medium (DMEM) (Pellgro) containing Cipro (10 mg l 21 ) (Invivogen). The samples were centrifuged at 5000 g for 10 min to remove debris. The supernatant containing the virus was used to inoculate 3-day-old BHK cells propagated in DMEM (Pellgro) with either plasmocin (25 mg l 21 ) (Invivogen) or normocin (100 mg l 21 ) (Invivogen) at 37 uC with 5 % CO 2 . The cultures were incubated at 37 uC in a CO 2 incubator and inspected daily for cytopathic changes (CPE). If CPE was noted, mediim was collected and analysed for EHDV by real-time quantitative reverse transcription PCR using EHDV-specific primers and probe (data not shown). EHDV positive cultures were harvested for serum neutralization testing and RNA extraction.
RNA isolation. BHK cells that showed 100 % CPE following EHDV virus infection were used for RNA extraction. Cell culture supernatant (20 ml) was filtered using 0.2 mm bottle-top filters (Thermo Scientific). The filtrate was centrifuged at 50 000 g for 2 h. Supernatant was discarded and the pellet was suspended in 1000 ml water. Samples were concentrated to a final 100 ml volume using Amicon ultracentrifugal filters (0.5 ml, 50 kDa) (Millipore). Cellular DNA and RNA were removed by incubation with DNase I (25 units) [New England Biolabs (NEB)] and RNase A (25 units) (Qiagen) at 37 uC for 1 h. RNA was extracted using QiaAmp viral RNA isolation kit (Qiagen) and eluted in 35 ml of the supplied elution buffer.
Genome amplification. Whole genome sequence of EHDV virus was obtained by sequence-independent cDNA synthesis methodology as described by Potgieter et al. (2009) , with some modifications. In brief, 10 ml dsRNA was ligated to PC3-T7 loop (200 ng) (59-p-GGATCCCGGGAATTCGGTAATACGACTCACTATATTTTTATAG-TGAGTCGTATTA-OH-39) in T4 RNA ligase buffer (NEB), 1 mM ATP (NEB), 10 % DMSO (Sigma Aldrich), 20 % polyethyleneglycol (PEG 6000 ) (Sigma Aldrich), 40 U RNasin (Promega) and 30 U T4 RNA ligase (NEB) in a final volume of 50 ml. The reaction mix was incubated at 16 uC overnight. Ligated dsRNA was purified using RNA 
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Clean & Concentrator (Zymo Research) according to the manufacturer's instructions. To the purified ligated dsRNA, DMSO (15 % (v/ v) final concentration) was added and incubated in a thermal cycler at 95 uC for 5 min and 4 uC for 5 min. RNA was reverse transcribed to cDNA using the GoScript Reverse Transcription system (Promega). The reaction was incubated in a thermal cycler at 25 uC for 15 min, 42 uC for 60 min and 5 uC for 15 min. RNA was removed using RNaseH (2.5 units, NEB) and incubated in a thermal cycler at 37 uC for 20 min. The cDNA was annealed at 65 uC for 4 h. cDNA was amplified using primer PC2 (59-p-CCGAATTCCCGGGATCC-39) in a PCR mixture containing 16 Ex Taq buffer, 0.2 mM dNTPs (NEB), 5 ml cDNA and 2.5 U TaKaRa Ex Taq (Clontech). The samples were incubated at 72 uC for 1 min. This was followed by an initial denaturation step of 94 uC for 2 min followed by 40 cycles of 94 uC for 30 s, 67 uC for 30 s and 72 uC for 4 min. A final extension step of 72 uC for 5 min was included. Amplified products were visualized after separation on 1.5 % agarose gels (TBE) containing ethidium bromide.
Sequencing and data analysis. Amplified products were sequenced using Ion Personal Genome Machine (PGM) sequencing platform (Life Technologies). In brief, the amplified products were fragmented, adaptor ligated and amplified using NEB Next Fast DNA Fragmentation and Library Prep Set 4 (NEB) according to the manufacturer's instructions. Fragments of sizes 300-330 bp were selected using AMPure XP bead size selection (Beckman Coulter) procedure according to the manufacturer's instructions. Quality of the amplified adaptor ligated DNA was checked using Qubit dsDNA HS Assay kit (Life Technologies). The samples were pooled in equal molar concentrations and the emulsion-based PCR was conducted using the Ion OneTouch 2 System (Life Technologies) according to the manufacturer's instructions. Percentage of templated ion sphere particles was checked using Ion Sphere Quality Control kit (Life Technologies). The templated ion spheres were loaded on the 314 chip (Life Technologies) and sequenced on the Ion Torrent Personal Genome Machine (PGM) system using the Ion PGM Template OT2 200 kit v2 (Life Technologies) according to the manufacturer's instructions. Sequence reads were assembled into contigs using the SeqMan NGen program (DNASTAR). Sequence data of each isolate were analysed using MEGA (version 5.05). Phylogenetic comparisons of VP1, VP2, VP3, VP4, VP5, VP6, VP7, NSP1, NSP2 and NSP3 nt sequences were conducted using maximum-likelihood analysis. Bootstrap confidence values were determined using 1000 replicates. Representative type 1, 2 and 6 viruses were submitted to GenBank under accession numbers KF570113 (type 1, VP1), KF570114 (type 1, VP2), KF570115 (type 1, VP3), KF570116 (type 1, VP4), KF570117 (type 1, VP5), KF570118 (type 1, VP6), KF570119 (type 1, VP7), KF570120 (type 1, NS1), KF570121 (type 1, NS2), KF570122 (type 1, NS3), KF570123 (type 2, VP1), KF570124 (type 2, VP2), KF570125 (type 2, VP3), KF570126 (type 2, VP4), KF570127 (type 2, VP5), KF570128 (type 2, VP6), KF570129 (type 2, VP7), KF570130 (type 2, NS1), KF570131 (type 2, NS2), KF570132 (type 2, NS3), KF570133 (type 6, VP1), KF570134 (type 6, VP2), KF570135 (type 6, VP3), KF570136 (type 6, VP4), KF570137 (type 6, VP5), KF570138 (type 6, VP6), KF570139 (type 6, VP7), KF570140 (type 6, NS1), KF570141 (type 6, NS2), KF570142 (type 6, NS3). Whole genome analysis of EHDV Serum neutralization assay. Antisera were diluted in DMEM serially twofold beginning at 1 : 2 and ending at 1 : 256 in a 96-well micro titre plate. Viruses were grown on BHK cells as described above. Viruses were diluted in DMEM to 200 TCID 50 per 100 ml as determined by titration on a monolayer of BHK cells. Diluted virus (100 ml) was added to every well of the diluted serum. The virus and antiserum mixture was incubated at 37 uC for 1 h in a humidified incubator with ±5 % CO 2 . To the virus and antiserum mixture, 150 ml Vero (African green monkey) cells (10 5 cells ml
21
) in DMEM supplemented with 5 % FCS was added. Controls consisting of cells only and cell plus antiserum were also included. Plates were incubated for 4-7 days at 37 uC in a humidified incubator with ±5 % CO 2 . Cells were visualized using an inverted microscope. Each well was observed for typical CPE and the wells were scored either positive or negative. Wells without CPE were considered positive for the presence of antibody. End-point titres were calculated by the reciprocal of the maximum dilution showing no CPE. The assay was considered valid only when the back titration average fell within 50 and 300 TCID 50 per well.
Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment. J Virol 87, 543-557. S. Anbalagan and others
